Skip to main content
Livermore
Livermore
ZHEN

Corbus Pharmaceuticals Holdings, Inc.

CRBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001595097

In the last 90 days, Corbus Pharmaceuticals Holdings, Inc. insiders filed 1 open-market purchase and 3 sales; 107 institutions reported holding it in 13F filings for Q2 2026, worth $129.1M in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Corbus Pharmaceuticals Holdings, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of CRBP: Q1 2024 compared with Q2 2024
MeasureQ1 2024Of which not filed for Q2 2024Q2 2024Change
Holders821107+26
Shares8.53M80010.8M+2.22M (+26.1%)
Value$334.7M$31.0K$486.1M+$151.4M (+45.2%)

1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (41)

Institutions that held Corbus Pharmaceuticals Holdings, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to CRBP in Q2 2024
InstitutionSharesValue% of portfolio
Darwin Global Management, Ltd.325,140$14.3M1.66%
Sio Capital Management, LLC225,165$10.2M3.84%
Avidity Partners Management LP215,600$9.76M0.41%
Vivo Capital, LLC166,794$7.55M0.70%
ExodusPoint Capital Management, LP116,271$5.26M0.06%
StemPoint Capital LP101,479$4.59M1.35%
Integral Health Asset Management, LLC100,000$4.53M0.45%
Verition Fund Management LLC72,842$3.30M0.03%
Acuta Capital Partners, LLC64,500$2.92M2.46%
Superstring Capital Management LP56,468$2.56M3.22%
Cinctive Capital Management LP49,013$2.22M0.12%
Wexford Capital LP44,156$2.00M0.51%
HighVista Strategies LLC38,793$1.76M0.64%
NEOS Investment Management LLC36,455$1.65M0.07%
Bank of New York Mellon Corp30,236$1.37M0.00%
Mirae Asset Global ETFs Holdings Ltd.30,124$1.36M0.00%
Charles Schwab Investment Management Inc28,843$1.31M0.00%
Nuveen Asset Management, LLC27,898$1.26M0.00%
Rafferty Asset Management, LLC23,212$1.05M0.00%
Zimmer Partners, LP20,600$932.1K0.02%
Artia Global Partners LP20,000$905.0K0.23%
Victory Capital Management Inc19,060$862.5K0.00%
ClariVest Asset Management LLC16,021$725.0K0.07%
Acadian Asset Management LLC15,854$716.0K0.00%
Rhumbline Advisers14,103$638.2K0.00%
EAM Investors, LLC12,609$570.6K0.09%
Jump Financial, LLC12,272$555.3K0.01%
Ameriprise Financial Inc11,414$516.5K0.00%
Gilder Gagnon Howe & Co LLC11,328$512.6K0.01%
Alliancebernstein L.P.7,210$326.3K0.00%
Susquehanna International Group, LLP5,838$264.2K0.00%
Corebridge Financial, Inc.5,467$247.4K0.00%
Invesco Ltd.4,784$216.5K0.00%
Deutsche Bank AG4,174$188.9K0.00%
New York State Common Retirement Fund4,100$185.5K0.00%
Legal & General Group Plc1,028$46.5K0.00%
Ameritas Investment Partners, Inc.996$45.1K0.00%
California State Teachers Retirement System736$33.3K0.00%
Amalgamated Bank352$16.0K0.00%
Pacer Advisors, Inc.132$5.97K0.00%
Unique Wealth Strategies, LLC33$1.29K0.00%

Sold out (15)

Institutions that held Corbus Pharmaceuticals Holdings, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of CRBP in Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Altitude Crest Partners Inc.103,703$4.07M
Prosight Management, LP100,617$3.95M
Eversept Partners, LP88,934$3.49M
Sphera Funds Management Ltd.35,000$1.37M
Mirae Asset Global Investments Co., Ltd.24,880$976.3K
Man Group plc17,673$693.5K
Squarepoint Ops LLC15,304$600.5K
Lighthouse Investment Partners, LLC14,943$586.4K
HRT Financial LP12,314$483.0K
XTX Topco Ltd10,290$403.8K
Renaissance Technologies LLC10,123$397.0K
UBS Oconnor LLC7,500$294.3K
Group One Trading, L.P.401$15.7K
IFP Advisors, Inc3$118
Macquarie Group Ltd507$20

Not filed for Q2 2024 yet (1)

Institutions that held Corbus Pharmaceuticals Holdings, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CRBP in Q1 2024 that haven't filed for Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Cutler Group LP800$31.0K